Bomox SA

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bomox SA

Understanding Bomox SA

Bomox SA is a pharmaceutical formulation classified as a long-acting or sustained-release bronchodilator. It is primarily utilized in the management of chronic respiratory conditions characterized by airflow obstruction, such as asthma and chronic obstructive pulmonary disease (COPD).

Composition and Mechanism

The medication contains active ingredients designed to relax the smooth muscles surrounding the airways in the lungs. By facilitating the opening of these passages, the medication helps to alleviate symptoms such as wheezing, shortness of breath, and chest tightness. The "SA" designation stands for sustained action, indicating that the medication is engineered to release its active components gradually over an extended period. This delivery method aims to provide consistent symptom control and reduce the frequency of administration compared to immediate-release alternatives.

Clinical Application

Bomox SA is typically used as a maintenance therapy. It is intended for regular, long-term use to keep the airways open and prevent the onset of respiratory distress. Because of its slow-release nature, it is not designed for the rapid relief of acute, sudden breathing difficulties or rescue situations.

In clinical practice, this medication may be used as a standalone treatment or in combination with other therapeutic agents, such as anti-inflammatory corticosteroids, depending on the specific needs and the severity of the respiratory condition being addressed.

Regulatory References

  1. World Health Organization (WHO)
  2. WHO Essential Medicines List

What side effects are possible with Bomox SA?

Possible Side Effects and Safety Information

The safety profile for Amoxicillin, the active ingredient in Bomox SA, is documented by regulatory authorities and organized by frequency and the body system affected. These classifications establish the risk framework for the medicine's use.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized based on the frequency observed in clinical and post-marketing surveillance:

Classification Examples of Reactions
Common Diarrhoea, Nausea, Rash
Uncommon Vomiting, Urticaria
Rare Reversible leukopenia, Convulsions, Hepatitis, Cholestatic jaundice

System-Organ-Class Safety Notes

The regulatory label groups documented effects by the physiological system involved. The most commonly reported system effects involve Gastrointestinal Disorders (e.g., Nausea, Diarrhoea) and Skin and Subcutaneous Tissue Disorders (e.g., Rash, Urticaria). Less frequently, effects are noted in the Blood and Lymphatic System and Hepato-biliary Disorders.

Documented Serious Adverse Reactions

The official safety information highlights rare but clinically significant events. These include severe allergic reactions such as Anaphylaxis and Angioedema. Very rare serious skin conditions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are also documented. Other serious events include Pseudomembranous colitis and adverse reactions affecting the kidney, such as Interstitial nephritis.

Contextual Safety Considerations

Certain official safety constraints exist, such as the contraindication for individuals with a history of hypersensitivity to any penicillin. Furthermore, the label notes that the risk of reactions such as Convulsions and Crystalluria may be heightened in patients with reduced renal function. Some hypersensitivity rashes may appear at the beginning of treatment, as documented in regulatory sources.

Overdose and Emergency Response

Overdosage of Bomox SA (Amoxicillin) is officially documented to present with initial gastrointestinal disturbances, including nausea, vomiting, and diarrhea. Overexposure may lead to severe manifestations involving the Central Nervous System (CNS) and the renal system. CNS effects noted in regulatory documentation include confusion, agitation, reversible hyperactivity, and convulsions. These neurological outcomes are particularly relevant in cases involving high doses or in patients with impaired renal function.

The most serious officially recognized complication is acute renal failure resulting from amoxicillin crystalluria or interstitial nephritis. This renal risk applies to both adult and pediatric patients. Regulatory guidance mandates that immediate medical attention must be sought in all suspected overdose situations.

Specifically, contacting emergency services or a poison control center is required if an individual exhibits severe, life-threatening symptoms such as collapse or having a seizure. Management is primarily supportive, as no specific chemical antidote is listed. Procedures described in official information include maintaining adequate fluid intake and diuresis to mitigate crystalluria risk. Hemodialysis is documented as a method to remove the drug from the body in severe cases.

Therapeutic Uses of Bomox SA

What Bomox SA Treats: Main Uses and Benefits

Bomox SA is a prescription antimicrobial agent applied across domains where additional symptomatic support is needed to address infections caused by susceptible bacteria. The medication is applied in clinical settings that involve acute or unstable symptom patterns, such as infections of the ear, nose, and throat (ENT) tract, lower respiratory tract (e.g., mild to moderate pneumonia), genitourinary tract (uncomplicated UTIs), and skin and skin structure.

The medicine helps address symptom clusters that may become intense or disruptive, including localized pain, fever, and inflammation, and is relevant when supportive symptom management is appropriate for community-acquired illnesses. It is relevant for managing symptoms that interfere with daily comfort.

It is commonly used across conditions presenting with acute episodes, assisting with maintaining functional stability during symptomatic periods.

This targeted approach helps improve day-to-day comfort during symptomatic periods, supporting general well-being during symptomatic phases. Furthermore, it is applied in specialized contexts, including supportive management of H. pylori infection and playing a role in managing the risk of infectious endocarditis.


Quick Fact: Relief for Acute Discomfort
This medicine is commonly used to help manage symptoms related to physical discomfort and inflammatory states caused by acute bacterial infections, assisting with maintaining functional stability during the symptomatic phase.

Eligibility and Restrictions for Use

Who can and cannot use Bomox SA?

The eligibility for using Bomox SA is strictly defined by government regulatory documents, focusing on patient history and physiological status.

Absolute Non-Eligibility (Contraindications): Bomox SA is strictly contraindicated for patients with a documented history of serious hypersensitivity reactions (e.g., anaphylaxis) to Amoxicillin or any other beta-lactam antibiotic, including penicillins and cephalosporins. Furthermore, the medicine should not be administered to individuals diagnosed with Infectious Mononucleosis, due to the high risk of developing a non-allergic skin rash.

Populations Requiring Conditional Use: Use is conditional for several groups. Patients with severe renal impairment must use Bomox SA under restricted conditions that require a mandatory dosage reduction. For age-related eligibility, use is established for adults and children over three months of age, but use in neonates and infants under three months is subject to dose limitations. Geriatric patients may require kidney function monitoring. Finally, pregnant women are advised to use the medicine only if clearly needed, and nursing mothers must exercise caution due to the risk of infant sensitization.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents establish specific interaction patterns for Amoxicillin (Bomox SA) with other medicinal products and substances, defining requirements for co-administration. These interactions are classified based on official descriptions of pharmacokinetic and pharmacodynamic outcomes.

Interaction Scope

Category Official Regulatory Information
Medicinal product categories with documented interactions Oral Anticoagulants; Other Antibacterials (bacteriostatic agents); Hormonal Contraceptives; Uricosuric Agents; Folic Acid Antagonists.
Specific interacting medicines (if explicitly listed) Probenecid; Allopurinol; Methotrexate.
Timing-based interaction rules (if applicable) No explicit mandatory time-separation rules are documented in the core regulatory labels.

Official Interaction Statements

Co-administration with Probenecid is officially described as a pharmacokinetic interaction that decreases the renal tubular secretion of Amoxicillin, resulting in increased and prolonged blood levels of the antibiotic. Due to this increased exposure, concurrent use is generally not recommended. When combined with Oral Anticoagulants, Amoxicillin may lead to a pharmacodynamic effect documented as an abnormal prolongation of prothrombin time (INR increase), requiring appropriate monitoring. The combination of Amoxicillin with Allopurinol is associated with an increased incidence of skin rash. Furthermore, Amoxicillin may reduce the effectiveness of combined oral contraceptives. In laboratory settings, high Amoxicillin concentrations may cause false-positive reactions when testing for glucose in urine using non-enzymatic methods. The medicine can be taken with or without food, as no interaction significantly affects absorption.

Mechanism of Action

How Bomox SA Works

Molecular Action: Irreversible Inhibition of Cell Wall Assembly

The mechanism of Amoxicillin, the active component of Bomox SA, is one of highly selective microbial destruction. Its primary action is the irreversible inhibition of specific bacterial enzymes called Penicillin-Binding Proteins (PBPs), which function as transpeptidases. Amoxicillin acts as a molecular mimic, binding covalently to the PBP active site and permanently deactivating the enzyme. This molecular interference prevents the final cross-linking of the peptidoglycan polymer in the bacterial cell wall, thereby halting the construction of the microbe’s essential structural layer.

Physiological Outcome: The Bactericidal Cascade

The failure to properly assemble the peptidoglycan layer triggers a cascade leading to cell rupture. The structural defect causes the bacteria’s own latent autolytic enzymes (autolysins) to become unopposed by synthesis. This combined action leaves the cell wall weakened, making the microbe unable to withstand its own high internal osmotic pressure. This molecular and cellular sequence results in the rupture and death of the susceptible bacterial pathogen (lysis), a process defined as the bactericidal action of the drug. The mechanism is constrained by bacterial production of beta-lactamases, which destroy the drug, and structural modification of PBP targets.

Dosage and Administration Information

How Bomox SA is Used: Official Administration Guidelines

Bomox SA, which contains the active ingredient Amoxicillin, is intended for oral administration using dosage forms such as capsules, tablets, and powders for oral suspension. The official instructions for use define strict parameters for dosing, frequency, duration, and patient-specific adjustments based on established clinical guidelines.


Dosing and Scheduling

Patient Group Standard Dosing Regimens (Adults ge 40 kg) Frequency Duration Pattern
Mild to Moderate Use 500 mg or 250 mg Every mathbf12 hours or Every mathbf8 hours Up to 10–14 days
Severe Use / Lower Respiratory 875 mg or 500 mg Every mathbf12 hours or Every mathbf8 hours Up to 10–14 days
Endocarditis Prophylaxis A single mathbf2 gram dose 30–60 minutes prior to procedure Single dose only

Pediatric dosing for patients weighing less than 40 kg is weight-based (mg/kg) and is divided into either 8-hour or 12-hour intervals.


Procedural Use and Special Populations

Administration Conditions: Bomox SA may be taken without regard to meals as its absorption is stable. However, the liquid suspension form must be reconstituted with water and shaken well prior to each dose, which must be measured using a calibrated device. Tablets and capsules are generally swallowed whole.

Course Duration: The full prescribed course must be completed, often for a minimum of 10 days for specific types of infections.

Dose Adjustment: Patients with severe renal impairment (Glomerular Filtration Rate < 30 mL/min) require dose reduction, and the high-strength mathbf875 mg dose is specifically prohibited in this population. For infants and neonates le mathbf3 months, the maximum dose is mathbf30 mg/kg/day divided every 12 hours.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Bomox SA

This overview summarizes the available research base for Bomox SA (Amoxicillin). It focuses on the types of studies conducted and what researchers have observed so far, without offering medical advice or making claims about what individual outcomes may be.


Evidence for Infections of the Respiratory and ENT Tract

The research for conditions like acute sinusitis, middle ear infections, and certain lower respiratory tract infections relies on Randomized Controlled Trials (RCTs), supported by Systematic Reviews and Meta-Analyses. These studies measured outcomes related to physical discomfort (like fever or pain) and assessed the status of pathogen clearance. Findings describe observed patterns in measured changes over the treatment period. However, research exploring short-term symptom changes for some mild infections indicated that the overall general recovery did not always differ significantly compared to control groups.


Evidence for Infections of the Genitourinary Tract and Skin

The research base for infections like acute cystitis and specific skin infections is derived from Clinical Trials and is documented in Official Regulatory Reviews. These studies monitored the status of bacteriological eradication and assessed patient-reported outcomes describing perceived discomfort and symptom changes. Research highlights changes measured during the study period that align with the medicine’s inclusion in regulatory assessments for these common scenarios. However, a key limitation is that comparative evidence is lacking in the form of recent, large-scale RCTs against newer therapies.


Evidence for Specialized Treatment Protocols and Prophylaxis

This medicine was studied for its use as a component in multi-drug treatment protocols, notably for Helicobacter pylori eradication, and was evaluated in prophylaxis studies exploring the patterns of infection risk. Prophylactic research explored patterns related to subsequent infectious events or tracked outcomes like the rate of early implant failure over defined time intervals. Findings indicate patterns of inclusion in standardized protocols. A limitation is that studies often do not isolate the measured effect of Bomox SA as a standalone agent.


Research Gaps and Areas of Uncertainty

The body of evidence contains several areas where certainty remains low. A primary gap is the need for more recent and comprehensive comparative evidence against newer antimicrobial classes. There is limited information for long-term outcomes regarding the durability of the measured response, and the long-term patterns observed in treated populations are not fully established by the currently published research.

Key Studies & References WHO Essential Medicines List (latest version, general use)

Frequently Asked Questions (FAQ)

Common questions about Bomox SA (FAQ)

Q: Are there any common foods or drinks to avoid while taking Bomox SA?

A: Official regulatory information states that Bomox SA may be taken without regard to meals, as food does not significantly impact how the medicine works. While no common foods are specifically restricted, official documents note that alcohol may worsen common side effects like nausea or diarrhea.

Q: Does Bomox SA interact with common over-the-counter pain relievers?

A: Regulatory documents list specific interactions with certain prescription medicines, such as Probenecid. Official documents list specific interactions but do not specifically address common over-the-counter pain relievers like ibuprofen or aspirin.

Q: Why is Bomox SA sometimes prescribed as 'SA' or 'Sustained-Action'?

A: The 'SA' indicates a Sustained-Action or Extended-Release formulation. This type of formulation is designed to release the active ingredient slowly over a longer time period, which allows for less frequent dosing, typically corresponding to a 12-hour interval.

Q: Does Bomox SA work right away, or does it take time to build up in the system?

A: The active ingredient in Bomox SA begins its antibacterial action immediately by interfering with bacterial cell wall growth. Official sources indicate that it may take 24 to 72 hours for changes in symptoms to be observed.

Q: Can older adults use Bomox SA without special precautions?

A: Official guidelines state that older adults may require caution during use. This is primarily because reduced kidney function is more common in this population, and monitoring or consideration of dosage adjustment may be necessary due to potential changes in renal function.

Q: Why do official sources list so many potential side effects for Bomox SA?

A: Regulatory agencies require that official documents list all adverse reactions that were observed and reported during clinical trials and post-marketing surveillance. This is done to fully document the known safety profile of the medicine for users.

Q: How does the sustained-action part of Bomox SA change how I take it?

A: The sustained-action (SA) formulation generally changes how often the medicine is taken. This formulation is associated with a less frequent dosing schedule compared to standard preparations.

Q: Is it normal to feel a bit nauseous when first starting Bomox SA?

A: Nausea is officially classified as a 'Common' adverse reaction for this medicine. Some regulatory reports indicate that gastrointestinal effects, such as nausea, may be reported when beginning treatment.

Q: Does Bomox SA interact with birth control pills?

A: Official regulatory documents caution that Amoxicillin, the active ingredient in Bomox SA, may reduce the effectiveness of combined oral contraceptives. This potential interaction is noted in the medication’s prescribing information.

Q: What are the most serious, but rare, side effects mentioned for Bomox SA?

A: The official safety documentation highlights rare but clinically significant events. These include severe allergic reactions like Anaphylaxis, serious skin conditions such as Stevens-Johnson Syndrome (SJS), and serious colon inflammation known as Pseudomembranous colitis.

Q: Is the 'SA' version designed to be taken less often?

A: Yes. The sustained-action formulation is designed to allow for less frequent administration compared to standard immediate-release preparations. This generally results in a less frequent administration schedule compared to immediate-release preparations.

Q: Can I take ibuprofen or aspirin with Bomox SA?

A: Official regulatory documents do not contain explicit warnings that common non-prescription pain relievers like ibuprofen or aspirin should not be taken with Bomox SA. Warnings typically focus on known interactions with certain prescription medicines, such as Probenecid.

Q: Is Bomox SA the same kind of medicine as other treatments for the same condition?

A: Bomox SA is in the pharmacological class of beta-lactam antibiotics, as it is a semi-synthetic derivative of penicillin. This places it in a different class than many other antibiotics that may be used to treat similar infections.

Q: How quickly should I expect to see an effect from Bomox SA?

A: While the medicine begins its action against bacteria quickly, official regulatory sources indicate that changes in symptoms may be observed between 24 and 72 hours.

Q: Does Bomox SA cause weight gain or weight loss?

A: Weight changes are not listed in the officially classified Common, Uncommon, or Rare adverse reactions for this medicine in major regulatory tables.

Q: Is it true that Bomox SA is a 'controlled substance'?

A: No. Official regulatory classification confirms that Amoxicillin, the active ingredient in Bomox SA, is not classified as a controlled substance in the United States or similar international scheduling systems.

Q: What should I do if I miss a dose of Bomox SA?

A: Official patient information describes taking the missed dose as soon as it is remembered. However, if the time for the next dose is near, the direction is to continue with the next scheduled dose and not take two doses.

Q: Can Bomox SA affect my ability to drive or operate machinery?

A: Official documentation notes that rare side effects such as convulsions or dizziness may occur, which could affect concentration or coordination. A general warning is included for these types of effects.

Q: Is Bomox SA safe for people with high blood pressure?

A: High blood pressure is not listed as a contraindication in the main regulatory documents for Bomox SA. The primary precaution regarding heart health relates to patients with reduced kidney function, which sometimes requires dosage modification.

Q: Are the side effects of Bomox SA temporary?

A: Many common side effects, especially gastrointestinal effects like nausea and diarrhea, are typically described in regulatory reports as mild and transient. This description suggests they are temporary and may resolve once the treatment course is completed.

Q: Is there a generic version of Bomox SA available?

A: Yes. The active ingredient in Bomox SA, Amoxicillin, is widely available in generic formulations, which are listed in official national drug databases.

Q: What happens if I stop taking Bomox SA suddenly?

A: The official instruction is to complete the entire prescribed course of treatment. Stopping the medicine suddenly or early may result in the re-emergence of the original infection or contribute to the development of drug-resistant bacteria.

Q: Does Bomox SA show up on a standard drug test?

A: The medicine itself is not typically screened for on standard workplace drug tests. While the active ingredient has been the subject of research on causing false-positive results, this is generally considered unlikely.

Q: Is Bomox SA known to cause problems with sleep?

A: Sleep disturbances, such as insomnia or trouble sleeping, are not classified as a common or uncommon side effect in major regulatory tables. However, somnolence (drowsiness) has been reported in post-marketing surveillance.

Q: Does my diet impact how well Bomox SA works?

A: Official regulatory documents state that Bomox SA can be taken with or without food. Its absorption and effectiveness are stable and not significantly impacted by the presence or absence of a meal.

Q: What is the difference between Bomox SA and just 'Bomox'?

A: The 'SA' indicates a Sustained-Action or Extended-Release formulation. This formulation results in a less frequent dosing schedule compared to standard preparations.

Q: Has Bomox SA been studied in long-term safety trials?

A: The official research overview indicates that there is limited available information in the medical literature regarding long-term outcomes for this medicine. Most studies focus on the short-term treatment of acute infections.

Q: Does Bomox SA have a risk of dependence or addiction?

A: Bomox SA is not classified as a controlled substance, and the active ingredient, Amoxicillin, is not associated with a risk of dependence or addiction in regulatory summaries.

Q: Is a headache a common side effect when starting Bomox SA?

A: Headache is not officially listed in the 'Common' category of adverse reactions in all major regulatory documents. However, some sources indicate it is a possible side effect that may be reported in the post-marketing setting.

Q: Can I drink alcohol while I am taking Bomox SA?

A: Core regulatory documents do not list alcohol as a direct contraindication or specific drug interaction that would cause a severe physical reaction. However, official information suggests that alcohol may worsen common gastrointestinal side effects like nausea and diarrhea.

Q: Does taking Bomox SA make me feel 'high' or 'drowsy'?

A: Feeling 'high' is not a documented effect in regulatory documents. While drowsiness (somnolence) is not a common side effect, it has been reported in post-marketing surveillance.

Q: What is the main benefit of using a sustained-action formula like Bomox SA?

A: The primary benefit of the sustained-action formulation is the convenience of a less frequent dosing schedule. This formulation is associated with the maintenance of drug levels in the bloodstream with fewer daily administrations.

Q: Is Bomox SA approved for treating anxiety or depression?

A: No. Official regulatory documents list the indications for use as the resolution of susceptible bacterial infections. Anxiety and depression are not listed as approved conditions for treatment.

Q: What is the intended duration of action for a single dose of Bomox SA?

A: The intended duration of action for a single dose of the Sustained-Action formulation is designed to align with the prescribed dosing frequency.

Q: Can Bomox SA affect my mood or behavior?

A: Rare adverse effects noted in regulatory reports under nervous system disorders include convulsions and agitation. More generally, some sources report anxiety or restlessness, although these are not classified as common effects.

Q: Can someone who has had heart problems safely use Bomox SA?

A: Official contraindications do not list general heart problems. Caution is mainly advised for patients with existing kidney impairment, a condition that may necessitate consideration of dosage modification.

Q: What is the purpose of the 'inactive ingredients' in Bomox SA tablets?

A: Inactive ingredients, also called excipients, are combined with the active ingredient for specific reasons. They help form the tablet's physical structure, ensure the drug is stable over time, and help the body absorb the medicine correctly.

Q: Why do some people say they get 'jitters' from Bomox SA?

A: While 'jitters' is not a medical term, official safety reports sometimes list related nervous system effects. These can include anxiety, restlessness, or agitation, though these are typically rare or of unknown frequency.

Q: Is Bomox SA used for anything other than its main indication?

A: Official regulatory documents only list the approved uses for the medicine, which is the resolution of susceptible bacterial infections. Discussion of any other uses is outside the scope of regulatory labels and therefore prohibited.

Q: Does Bomox SA cause dry mouth?

A: Dry mouth is not listed as a common or uncommon side effect in major regulatory summaries. However, it has been reported in post-marketing surveillance with an incidence that is not known.

How should Bomox SA be stored and disposed of?

How to Store and Dispose of Bomox SA

The storage and disposal instructions for Bomox SA (Amoxicillin) must comply with official regulatory labeling to maintain the product's quality.

Storage Requirements

Condition Requirement
Temperature Store capsules and tablets at controlled room temperature, specifically 20 C to 25 C (68 F to 77 F).
Protection Keep the medicine in its original container, tightly closed, and protected from moisture.
Child Safety Must be stored out of the sight and reach of children.
Suspension Stability Reconstituted oral suspension has a limited stability period of 14 days and must not be frozen.

Disposal

Unused or expired Bomox SA must be discarded following local governmental pharmaceutical waste protocols. Disposal should not occur via wastewater or household waste. Patients are advised to utilize approved drug take-back programs where available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bomox SA found in:

A-Z Index: